Eletriptan 40 MG Oral Tablet — RxCUI 359494
RxNorm drug concept · Semantic clinical drug
RxCUI 359494
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI359494
Official nameEletriptan 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aseletriptan 40 MG (as eletriptan HBr 48.5 MG) Oral Tablet; eletriptan HBr 40 MG Oral Tablet
FDA products mapped21
Package NDCs mapped38
Reported Medicaid activity (SDUD)35,726 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Eletriptan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Eletriptan works by narrowing blood vessels around the brain that widen during a migraine and by blocking the release of pain-causing chemicals from the nerve system involved in mi...
- What exactly does eletriptan do — and how quickly does it work?
- Yes — if your headache hasn't resolved 2 hours after your first dose, or if it comes back after initially feeling better, you can take a second dose. But you must wait at least 2 f...
- Can I take a second dose if my migraine doesn't go away?
🕸️ Concept Web — How Eletriptan 40 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Eletriptan 40 MG Oral Tablet
RxCUI 359494 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Eletriptan
231049IN
-
Eletriptan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Relpax
353724BN
-
Relpax
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Eletriptan Oral Tablet
379029SCDF -
Eletriptan Oral Product
1161297SCDG -
Eletriptan Pill
1161298SCDG -
Eletriptan Oral Tablet [Relpax]
406251SBDF -
Relpax Oral Product
1180711SBDG -
Relpax Pill
1180712SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Eletriptan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Eletriptan 40 MG
360289SCDC -
Eletriptan 40 MG Oral Tablet [Relpax]
404444SBD -
Eletriptan 40 MG [Relpax]
576401SBDC
-
Eletriptan 40 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Eletriptan 40 MG
SCDC · 360289 -
Eletriptan Oral Tablet
SCDF · 379029 -
Eletriptan Oral Product
SCDG · 1161297 -
Eletriptan Pill
SCDG · 1161298
Brand-Name Concepts
-
Eletriptan 40 MG Oral Tablet [Relpax]
SBD · 404444 -
Eletriptan 40 MG [Relpax]
SBDC · 576401 -
Eletriptan Oral Tablet [Relpax]
SBDF · 406251 -
Relpax Oral Product
SBDG · 1180711 -
Relpax Pill
SBDG · 1180712 -
Relpax
BN · 353724
📦 FDA Products & Package NDCs
21 products · 38 package NDCs
38 package NDCs map to RxCUI 359494 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-8310-18 | 6 BLISTER PACK in 1 CARTON (0093-8310-18) / 1 TABLET, FILM... | Eletriptan Hydrobromide | Teva Pharmaceuticals USA, Inc. | 2017-07-21 |
| 00093-8311-18 | 6 BLISTER PACK in 1 CARTON (0093-8311-18) / 1 TABLET, FILM... | Eletriptan Hydrobromide | Teva Pharmaceuticals USA, Inc. | 2017-07-21 |
| 00378-4287-85 | 1 BLISTER PACK in 1 CARTON (0378-4287-85) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Mylan Pharmaceuticals Inc. | 2017-08-15 |
| 00378-4288-08 | 2 BLISTER PACK in 1 CARTON (0378-4288-08) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Mylan Pharmaceuticals Inc. | 2017-08-16 |
| 00378-4288-85 | 1 BLISTER PACK in 1 CARTON (0378-4288-85) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Mylan Pharmaceuticals Inc. | 2017-08-15 |
| 24689-0167-01 | 100 TABLET, FILM COATED in 1 BOTTLE (24689-167-01) | Eletriptan Hydrobromide | Apnar Pharma LP | 2026-05-13 |
| 24689-0168-01 | 100 TABLET, FILM COATED in 1 BOTTLE (24689-168-01) | Eletriptan Hydrobromide | Apnar Pharma LP | 2026-05-13 |
| 31722-0443-31 | 1 BLISTER PACK in 1 CARTON (31722-443-31) / 6 TABLET, FILM... | Eletriptan hydrobromide | Camber Pharmaceuticals, Inc. | 2025-07-07 |
| 31722-0444-31 | 1 BLISTER PACK in 1 CARTON (31722-444-31) / 6 TABLET, FILM... | Eletriptan hydrobromide | Camber Pharmaceuticals, Inc. | 2025-07-07 |
| 31722-0444-33 | 2 BLISTER PACK in 1 CARTON (31722-444-33) / 6 TABLET, FILM... | Eletriptan hydrobromide | Camber Pharmaceuticals, Inc. | 2025-07-07 |
| 58151-0367-56 | 6 BLISTER PACK in 1 CARTON (58151-367-56) / 1 TABLET in 1 B... | Relpax | Viatris Specialty LLC | 2025-05-08 |
| 58151-0368-56 | 6 BLISTER PACK in 1 CARTON (58151-368-56) / 1 TABLET in 1 B... | Relpax | Viatris Specialty LLC | 2024-08-21 |
| 58151-0368-96 | 12 BLISTER PACK in 1 CARTON (58151-368-96) / 1 TABLET in 1... | Relpax | Viatris Specialty LLC | 2025-01-23 |
| 59651-0104-69 | 1 BLISTER PACK in 1 CARTON (59651-104-69) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Aurobindo Pharma Limited | 2019-01-15 |
| 59651-0105-69 | 1 BLISTER PACK in 1 CARTON (59651-105-69) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Aurobindo Pharma Limited | 2019-01-15 |
| 59651-0105-93 | 2 BLISTER PACK in 1 CARTON (59651-105-93) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Aurobindo Pharma Limited | 2019-01-15 |
| 63629-8320-01 | 9 TABLET, FILM COATED in 1 BOTTLE (63629-8320-1) | Eletriptan Hydrobromide | Bryant Ranch Prepack | 2020-05-18 |
| 63629-8320-02 | 30 TABLET, FILM COATED in 1 BOTTLE (63629-8320-2) | Eletriptan Hydrobromide | Bryant Ranch Prepack | 2021-12-07 |
| 68382-0922-06 | 30 TABLET, FILM COATED in 1 BOTTLE (68382-922-06) | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0922-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (68382-922-10) | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0922-77 | 10 BLISTER PACK in 1 CARTON (68382-922-77) / 10 TABLET, FIL... | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0922-86 | 1 BLISTER PACK in 1 CARTON (68382-922-86) / 6 TABLET, FILM... | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0923-05 | 500 TABLET, FILM COATED in 1 BOTTLE (68382-923-05) | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0923-06 | 30 TABLET, FILM COATED in 1 BOTTLE (68382-923-06) | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0923-77 | 10 BLISTER PACK in 1 CARTON (68382-923-77) / 10 TABLET, FIL... | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 68382-0923-86 | 1 BLISTER PACK in 1 CARTON (68382-923-86) / 6 TABLET, FILM... | Eletriptan hydrobromide | Zydus Pharmaceuticals USA Inc. | 2017-07-12 |
| 70771-1107-00 | 1000 TABLET, FILM COATED in 1 BOTTLE (70771-1107-0) | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1107-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1107-3) | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1107-04 | 10 BLISTER PACK in 1 CARTON (70771-1107-4) / 10 TABLET, FIL... | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1107-06 | 1 BLISTER PACK in 1 CARTON (70771-1107-6) / 6 TABLET, FILM... | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1108-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1108-3) | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1108-04 | 10 BLISTER PACK in 1 CARTON (70771-1108-4) / 10 TABLET, FIL... | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1108-05 | 500 TABLET, FILM COATED in 1 BOTTLE (70771-1108-5) | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 70771-1108-06 | 1 BLISTER PACK in 1 CARTON (70771-1108-6) / 6 TABLET, FILM... | Eletriptan hydrobromide | Zydus Lifesciences Limited | 2017-07-12 |
| 71335-2983-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2983-1) | Eletriptan hydrobromide | Bryant Ranch Prepack | 2026-02-04 |
| 72189-0439-06 | 6 TABLET, FILM COATED in 1 CARTON (72189-439-06) | Eletriptan HBR | Direct_Rx | 2023-03-14 |
| 72189-0517-06 | 6 TABLET, FILM COATED in 1 CARTON (72189-517-06) | Eletriptan HBR | Direct_Rx | 2023-10-11 |
| 80425-0408-01 | 1 BLISTER PACK in 1 CARTON (80425-0408-1) / 6 TABLET, FILM... | Eletriptan Hydrobromide | Advanced Rx of Tennessee, LLC | 2024-06-25 |
Observed labelers:
Zydus Lifesciences Limited (8) ·
Zydus Pharmaceuticals USA Inc. (8) ·
Aurobindo Pharma Limited (3) ·
Bryant Ranch Prepack (3) ·
Camber Pharmaceuticals, Inc. (3) ·
Mylan Pharmaceuticals Inc. (3)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.